IDiyas

For the Inventor, By the Inventor

Pomona, NY, United States of America

Janis Upeslacis

USPTO Granted Patents = 15

Average Co-Inventor Count = 3.0

ph-index = 7

Forward Citations = 578(Granted Patents)


Company Filing History:

goldMedal15 out of 3,580 
 
American Cyanamid Company
 patents

Years Active: 1983-1998

Loading Chart...
15 patents (USPTO):Explore Patents
1. 5770701 - Process for preparing targeted forms of methyltrithio antitumor agents (1998-06-23),
2. 5053394 - Targeted forms of methyltrithio antitumor agents (1991-10-01),
3. 4732970 - Antitumor amino acid and peptide derivatives of 1,4-bis(aminoalkyl and (1988-03-22),
4. 4670421 - Antiatherosclerotic silanes (1987-06-02),
5. 4603145 - Antiatherosclerotic diphenyl alkanamides (1986-07-29),
6. 4536346 - Aralkanamidophenyl compounds (1985-08-20),
7. 4489094 - Arylalkylaminobenzoic acids (1984-12-18),
8. 4440758 - Poly-cation salts of bis(or tris)[4-O-monohexose-oxy]-arylene sulfate (1984-04-03),
9. 4435387 - Poly-cation salts of bis (or tris) 4-O-polyhexose-thio-arylene sulfate (1984-03-06),
10. 4431638 - Poly-cation salts of bis(or tris)[4-0-monohexose-thio]-arylene sulfate (1984-02-14),
11. 4431637 - Polycation salts of bis (or tris) [4-O-polyhexose-oxy]-arylene sulfate (1984-02-14),
12. 4431636 - Bis(4-O-polyhexaose-thio)-phenyl ureas and method of use (1984-02-14),
13. 4404195 - Poly cation salts of monohexosethio (or oxy) alkyl diamides (1983-09-13),
14. 4401661 - N,N'-Bis(glucopyranosyl-D-glucopyranosyloxyphenyl)alkaline and methods (1983-08-30),
15. 4399126 - Modulators of the complement system (1983-08-16),

Title: Inventor Spotlight: Janis Upeslacis and Her Remarkable Contributions to Antitumor Research

Introduction:

Janis Upeslacis is an esteemed inventor hailing from Pomona, NY, with a remarkable portfolio of fifteen patents to her name. Her significant contributions to the field of pharmaceuticals, specifically in developing targeted antitumor agents, demonstrate her dedication to enhancing cancer treatments and improving patient outcomes.

Latest Patents:

Janis's latest patents include groundbreaking research on the "Process for Preparing Targeted Forms of Methyltrithio Antitumor Agents." This disclosure details a novel method for constructing targeting agent-drug conjugates from the family of methyltrithio antibacterial and antitumor agents. Another notable patent, "Targeted Forms of Methyltrithio Antitumor Agents," further elaborates on creating carrier-drug conjugates within the same family, emphasizing the innovative approaches she is employing to tackle complex medical challenges.

Career Highlights:

Janis Upeslacis has made significant strides in her career while working at the American Cyanamid Company. Her research focuses on advancing methods to improve the delivery and efficacy of antitumor treatments, showcasing her commitment to innovation in the pharmaceutical industry.

Collaborations:

Throughout her career, Janis has had the privilege of working alongside fellow innovators Robert E. Schaub and Seymour Bernstein. Their collaborative efforts have contributed to the development of advanced therapeutic solutions aimed at fighting cancer, highlighting the importance of teamwork in the field of research and development.

Conclusion:

In summary, Janis Upeslacis stands out as a prominent inventor in the pharmaceutical realm with her dedicated work on methyltrithio antitumor agents. Her innovative patents and collaborative spirit continue to pave the way for advancements in cancer treatment, making her a key figure in the ongoing fight against this disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…